Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
iCare, part of the Revenio Group, and the U.S.-driven eye health innovation organization EyeCheq, have entered into a collaborative agreement and strategic minority investment to increase access to po...
AnalytiChem expanded CONOSTAN into ASTM D3606 fuel speciation with standardized calibration curve kits and check standards aligned to both method procedures. AnalytiChem, a dealer of specialty chemic...
Strengthens focus as a devoted MedTech company and develops its three-phase transformation approaches. Positions Health Information Systems, a leading, scaled, medical care software business, to speed...
Haut.AI Launches AI-Powered Clinical Studies Software for Large-Scale Skin Studies Across Clinic, Hybrid, and At-Home Environments Haut.AI has launched its AI-driven Clinical Research Software, a val...
Siemens Healthineers and Cleveland Clinic Launch 10-year Strategic Alliance to Enhance Care Through Clinical Innovation and Advanced Imaging Siemens Healthineers and Cleveland Clinic have expanded th...
Perma-Fix Environmental Services and Mirion Technologies have officially formed a strategic partnership to target Department of Energy (DOE) and federal nuclear cleanup opportunities. Perma-Fix Envi...
Chemists at Northwestern University effectively repurposed flexible DNA strands as a programmable "molecular glue" to guide proteins into accurate crystal structures. Researchers have massively relie...
Quibim has launched QP-Breast, an AI-driven decision-support device which automatically identifies lesions doubtful for breast cancer on MRI, making it the first such device to receive both CE and UKC...
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Management of Geographic Atrophy, Secondary to Dry Age-Rela...
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia Vertex Pharmaceutic...
Speak with a healthcare analyst about your research, consulting, or platform needs.